Goldman Sachs updated its Sharpe Ratio basket, a list of 50 stocks with the highest expected risk-adjusted returns in the ...

Moderna’s first quarter results were met with a negative market reaction, as revenue fell short of Wall Street expectations ...

Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) shares fell 2.2% Thursday as the company confirmed it is seeking outside investment to support its late-stage vaccine programs. The move underscores the biotech ...

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...

Novavax, Inc. (NASDAQ:NVAX) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 2:00 PM ETCompany ParticipantsJames Patrick Kelly - ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

In a report released on June 18, Courtney Breen from Bernstein maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of $350.00. The company’s shares ...

WHEN I look around the business landscape, one thing is crystal clear: generative artificial intelligence (AI) isn't just a new tool — it's a force reshaping entire companies. I don't mean startups or ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Merck & Company (MRK – Research Report). The company’s shares closed yesterday at $81 ...